This compound is a triazolopyridine derivative featuring a formylphenyl group and a cyclopropanecarboxamide moiety. It is primarily known as a pharmaceutical intermediate used in the synthesis of Filgotinib.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1206163-55-4
N-(5-(4-(hydroxymethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
pharmaceutical intermediate
(5-Bromo-3-(trifluoromethyl)pyridin-2-yl)methanol
pharmaceutical intermediate
5-Deamino-5-oxo Amiloride Hydrochloride
pharmaceutical intermediate
(2S,3S)-2-amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid
pharmaceutical intermediate
(5R,6S)-6-[(1R)-1-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 2-propenyl ester
pharmaceutical intermediate
N-(5-(4-(bromomethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
pharmaceutical intermediate
N-[5-(4-formylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
ADQKDLGWFSVVAN-UHFFFAOYSA-N
C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)C=O
—